SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-039727
Filing Date
2021-03-22
Accepted
2021-03-22 16:30:23
Documents
2
Period of Report
2021-03-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2110522-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2110522-1_3seq1.xml 3 5260
2 EXHIBIT 24.1 tm2110522d1_ex24-1.htm EX-24.1 6904
  Complete submission text file 0001104659-21-039727.txt   13586
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Issuer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HOOKIPA PHARMA INC. 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118
Business Address
Baker Christine D. (Reporting) CIK: 0001852644 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38869 | Film No.: 21761669